- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
According to our latest study, the global Neurogenetic Testing market size was valued at USD 490.8 million in 2022 and is forecast to a readjusted size of USD 1034.8 million by 2029 with a CAGR of 11.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of neurogenetic testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, etc. The top five players hold a share over 28%. In terms of product type, Exome Sequencing is the largest segment, occupied for a share of 44%, and in terms of application, Hospitals has a share about 46 percent.
This report is a detailed and comprehensive analysis for global Neurogenetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neurogenetic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Neurogenetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Neurogenetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Neurogenetic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neurogenetic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neurogenetic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina and Labcorp, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Neurogenetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Market segment by Application
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Market segment by players, this report covers
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp
Invitae
MedGenome Labs
Connecticut Children’s
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Neurogenetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurogenetic Testing, with revenue, gross margin and global market share of Neurogenetic Testing from 2018 to 2023.
Chapter 3, the Neurogenetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neurogenetic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurogenetic Testing.
Chapter 13, to describe Neurogenetic Testing research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Neurogenetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurogenetic Testing by Type
1.3.1 Overview: Global Neurogenetic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Neurogenetic Testing Consumption Value Market Share by Type in 2022
1.3.3 Exome Sequencing
1.3.4 Whole Genome Sequencing
1.3.5 RNA Sequencing
1.3.6 General DNA Testing
1.4 Global Neurogenetic Testing Market by Application
1.4.1 Overview: Global Neurogenetic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Research Institutes
1.4.5 Diagnostics Laboratories
1.5 Global Neurogenetic Testing Market Size & Forecast
1.6 Global Neurogenetic Testing Market Size and Forecast by Region
1.6.1 Global Neurogenetic Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Neurogenetic Testing Market Size by Region, (2018-2029)
1.6.3 North America Neurogenetic Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Neurogenetic Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Neurogenetic Testing Market Size and Prospect (2018-2029)
1.6.6 South America Neurogenetic Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Neurogenetic Testing Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business
2.1.3 Quest Diagnostics Neurogenetic Testing Product and Solutions
2.1.4 Quest Diagnostics Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Quest Diagnostics Recent Developments and Future Plans
2.2 Mayo Clinic
2.2.1 Mayo Clinic Details
2.2.2 Mayo Clinic Major Business
2.2.3 Mayo Clinic Neurogenetic Testing Product and Solutions
2.2.4 Mayo Clinic Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mayo Clinic Recent Developments and Future Plans
2.3 GeneDx
2.3.1 GeneDx Details
2.3.2 GeneDx Major Business
2.3.3 GeneDx Neurogenetic Testing Product and Solutions
2.3.4 GeneDx Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GeneDx Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Neurogenetic Testing Product and Solutions
2.4.4 Illumina Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Labcorp
2.5.1 Labcorp Details
2.5.2 Labcorp Major Business
2.5.3 Labcorp Neurogenetic Testing Product and Solutions
2.5.4 Labcorp Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Labcorp Recent Developments and Future Plans
2.6 Invitae
2.6.1 Invitae Details
2.6.2 Invitae Major Business
2.6.3 Invitae Neurogenetic Testing Product and Solutions
2.6.4 Invitae Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Invitae Recent Developments and Future Plans
2.7 MedGenome Labs
2.7.1 MedGenome Labs Details
2.7.2 MedGenome Labs Major Business
2.7.3 MedGenome Labs Neurogenetic Testing Product and Solutions
2.7.4 MedGenome Labs Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MedGenome Labs Recent Developments and Future Plans
2.8 Connecticut Children’s
2.8.1 Connecticut Children’s Details
2.8.2 Connecticut Children’s Major Business
2.8.3 Connecticut Children’s Neurogenetic Testing Product and Solutions
2.8.4 Connecticut Children’s Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Connecticut Children’s Recent Developments and Future Plans
2.9 CENTOGENE
2.9.1 CENTOGENE Details
2.9.2 CENTOGENE Major Business
2.9.3 CENTOGENE Neurogenetic Testing Product and Solutions
2.9.4 CENTOGENE Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CENTOGENE Recent Developments and Future Plans
2.10 Victorian Clinical Genetics Services
2.10.1 Victorian Clinical Genetics Services Details
2.10.2 Victorian Clinical Genetics Services Major Business
2.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Product and Solutions
2.10.4 Victorian Clinical Genetics Services Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Victorian Clinical Genetics Services Recent Developments and Future Plans
2.11 PacBio
2.11.1 PacBio Details
2.11.2 PacBio Major Business
2.11.3 PacBio Neurogenetic Testing Product and Solutions
2.11.4 PacBio Neurogenetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PacBio Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Neurogenetic Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Neurogenetic Testing by Company Revenue
3.2.2 Top 3 Neurogenetic Testing Players Market Share in 2022
3.2.3 Top 6 Neurogenetic Testing Players Market Share in 2022
3.3 Neurogenetic Testing Market: Overall Company Footprint Analysis
3.3.1 Neurogenetic Testing Market: Region Footprint
3.3.2 Neurogenetic Testing Market: Company Product Type Footprint
3.3.3 Neurogenetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Neurogenetic Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Neurogenetic Testing Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Neurogenetic Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Neurogenetic Testing Market Forecast by Application (2024-2029)
6 North America
6.1 North America Neurogenetic Testing Consumption Value by Type (2018-2029)
6.2 North America Neurogenetic Testing Consumption Value by Application (2018-2029)
6.3 North America Neurogenetic Testing Market Size by Country
6.3.1 North America Neurogenetic Testing Consumption Value by Country (2018-2029)
6.3.2 United States Neurogenetic Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Neurogenetic Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Neurogenetic Testing Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Neurogenetic Testing Consumption Value by Type (2018-2029)
7.2 Europe Neurogenetic Testing Consumption Value by Application (2018-2029)
7.3 Europe Neurogenetic Testing Market Size by Country
7.3.1 Europe Neurogenetic Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Neurogenetic Testing Market Size and Forecast (2018-2029)
7.3.3 France Neurogenetic Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Neurogenetic Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Neurogenetic Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Neurogenetic Testing Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Neurogenetic Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Neurogenetic Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Neurogenetic Testing Market Size by Region
8.3.1 Asia-Pacific Neurogenetic Testing Consumption Value by Region (2018-2029)
8.3.2 China Neurogenetic Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Neurogenetic Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Neurogenetic Testing Market Size and Forecast (2018-2029)
8.3.5 India Neurogenetic Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Neurogenetic Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Neurogenetic Testing Market Size and Forecast (2018-2029)
9 South America
9.1 South America Neurogenetic Testing Consumption Value by Type (2018-2029)
9.2 South America Neurogenetic Testing Consumption Value by Application (2018-2029)
9.3 South America Neurogenetic Testing Market Size by Country
9.3.1 South America Neurogenetic Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Neurogenetic Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Neurogenetic Testing Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Neurogenetic Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Neurogenetic Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Neurogenetic Testing Market Size by Country
10.3.1 Middle East & Africa Neurogenetic Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Neurogenetic Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Neurogenetic Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Neurogenetic Testing Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Neurogenetic Testing Market Drivers
11.2 Neurogenetic Testing Market Restraints
11.3 Neurogenetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Neurogenetic Testing Industry Chain
12.2 Neurogenetic Testing Upstream Analysis
12.3 Neurogenetic Testing Midstream Analysis
12.4 Neurogenetic Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neurogenetic Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Neurogenetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Neurogenetic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Quest Diagnostics Major Business
Table 7. Quest Diagnostics Neurogenetic Testing Product and Solutions
Table 8. Quest Diagnostics Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Quest Diagnostics Recent Developments and Future Plans
Table 10. Mayo Clinic Company Information, Head Office, and Major Competitors
Table 11. Mayo Clinic Major Business
Table 12. Mayo Clinic Neurogenetic Testing Product and Solutions
Table 13. Mayo Clinic Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Mayo Clinic Recent Developments and Future Plans
Table 15. GeneDx Company Information, Head Office, and Major Competitors
Table 16. GeneDx Major Business
Table 17. GeneDx Neurogenetic Testing Product and Solutions
Table 18. GeneDx Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. GeneDx Recent Developments and Future Plans
Table 20. Illumina Company Information, Head Office, and Major Competitors
Table 21. Illumina Major Business
Table 22. Illumina Neurogenetic Testing Product and Solutions
Table 23. Illumina Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Illumina Recent Developments and Future Plans
Table 25. Labcorp Company Information, Head Office, and Major Competitors
Table 26. Labcorp Major Business
Table 27. Labcorp Neurogenetic Testing Product and Solutions
Table 28. Labcorp Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Labcorp Recent Developments and Future Plans
Table 30. Invitae Company Information, Head Office, and Major Competitors
Table 31. Invitae Major Business
Table 32. Invitae Neurogenetic Testing Product and Solutions
Table 33. Invitae Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Invitae Recent Developments and Future Plans
Table 35. MedGenome Labs Company Information, Head Office, and Major Competitors
Table 36. MedGenome Labs Major Business
Table 37. MedGenome Labs Neurogenetic Testing Product and Solutions
Table 38. MedGenome Labs Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. MedGenome Labs Recent Developments and Future Plans
Table 40. Connecticut Children’s Company Information, Head Office, and Major Competitors
Table 41. Connecticut Children’s Major Business
Table 42. Connecticut Children’s Neurogenetic Testing Product and Solutions
Table 43. Connecticut Children’s Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Connecticut Children’s Recent Developments and Future Plans
Table 45. CENTOGENE Company Information, Head Office, and Major Competitors
Table 46. CENTOGENE Major Business
Table 47. CENTOGENE Neurogenetic Testing Product and Solutions
Table 48. CENTOGENE Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. CENTOGENE Recent Developments and Future Plans
Table 50. Victorian Clinical Genetics Services Company Information, Head Office, and Major Competitors
Table 51. Victorian Clinical Genetics Services Major Business
Table 52. Victorian Clinical Genetics Services Neurogenetic Testing Product and Solutions
Table 53. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Victorian Clinical Genetics Services Recent Developments and Future Plans
Table 55. PacBio Company Information, Head Office, and Major Competitors
Table 56. PacBio Major Business
Table 57. PacBio Neurogenetic Testing Product and Solutions
Table 58. PacBio Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. PacBio Recent Developments and Future Plans
Table 60. Global Neurogenetic Testing Revenue (USD Million) by Players (2018-2023)
Table 61. Global Neurogenetic Testing Revenue Share by Players (2018-2023)
Table 62. Breakdown of Neurogenetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Neurogenetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Neurogenetic Testing Players
Table 65. Neurogenetic Testing Market: Company Product Type Footprint
Table 66. Neurogenetic Testing Market: Company Product Application Footprint
Table 67. Neurogenetic Testing New Market Entrants and Barriers to Market Entry
Table 68. Neurogenetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Neurogenetic Testing Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Neurogenetic Testing Consumption Value Share by Type (2018-2023)
Table 71. Global Neurogenetic Testing Consumption Value Forecast by Type (2024-2029)
Table 72. Global Neurogenetic Testing Consumption Value by Application (2018-2023)
Table 73. Global Neurogenetic Testing Consumption Value Forecast by Application (2024-2029)
Table 74. North America Neurogenetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Neurogenetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Neurogenetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Neurogenetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Neurogenetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Neurogenetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Neurogenetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Neurogenetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Neurogenetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Neurogenetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Neurogenetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Neurogenetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Neurogenetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Neurogenetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Neurogenetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Neurogenetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Neurogenetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Neurogenetic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Neurogenetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Neurogenetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Neurogenetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Neurogenetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Neurogenetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Neurogenetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Neurogenetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Neurogenetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Neurogenetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Neurogenetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Neurogenetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Neurogenetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Neurogenetic Testing Raw Material
Table 105. Key Suppliers of Neurogenetic Testing Raw Materials
List of Figures
Figure 1. Neurogenetic Testing Picture
Figure 2. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neurogenetic Testing Consumption Value Market Share by Type in 2022
Figure 4. Exome Sequencing
Figure 5. Whole Genome Sequencing
Figure 6. RNA Sequencing
Figure 7. General DNA Testing
Figure 8. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Neurogenetic Testing Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Picture
Figure 11. Specialty Clinics Picture
Figure 12. Research Institutes Picture
Figure 13. Diagnostics Laboratories Picture
Figure 14. Global Neurogenetic Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Neurogenetic Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Neurogenetic Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Neurogenetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Neurogenetic Testing Consumption Value Market Share by Region in 2022
Figure 19. North America Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Neurogenetic Testing Revenue Share by Players in 2022
Figure 25. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Neurogenetic Testing Market Share in 2022
Figure 27. Global Top 6 Players Neurogenetic Testing Market Share in 2022
Figure 28. Global Neurogenetic Testing Consumption Value Share by Type (2018-2023)
Figure 29. Global Neurogenetic Testing Market Share Forecast by Type (2024-2029)
Figure 30. Global Neurogenetic Testing Consumption Value Share by Application (2018-2023)
Figure 31. Global Neurogenetic Testing Market Share Forecast by Application (2024-2029)
Figure 32. North America Neurogenetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Neurogenetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Neurogenetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Neurogenetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Neurogenetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Neurogenetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. France Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 49. China Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. India Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Neurogenetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Neurogenetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Neurogenetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Neurogenetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 66. Neurogenetic Testing Market Drivers
Figure 67. Neurogenetic Testing Market Restraints
Figure 68. Neurogenetic Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neurogenetic Testing in 2022
Figure 71. Manufacturing Process Analysis of Neurogenetic Testing
Figure 72. Neurogenetic Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
